The invention provides two crystalline freebase forms of biphenyl-2-ylcarbamicacid 1 -(2-{ [4-(4-carbamoylpiperidin- 1 -ylmethyl)benzoyl]methylamino }ethyl)piperidin-4-yl ester.The invention also provides pharmaceutical compositions comprising thecrystallinefreebase or prepared using the crystalline freebases; processes andintermediates forpreparing the crystalline freebases; and methods of using the crystallinefreebases that maybe useful to treat a pulmonary disorder.